HSD17B13 and metabolic dysfunction-associated steatohepatitis: In addition, HSD17B13 stabilized intracellular TGs and thus might cause unbalance of LDs in the liver, which might hinder autophagy and lipolysis processes, and sequentially worsen liver steatosis to NASH [47].